Logo image of MYPS

PLAYSTUDIOS INC (MYPS) Stock Fundamental Analysis

USA - NASDAQ:MYPS - US72815G1085 - Common Stock

0.95 USD
+0.01 (+0.76%)
Last: 10/3/2025, 8:00:01 PM
0.95 USD
0 (0%)
After Hours: 10/3/2025, 8:00:01 PM
Fundamental Rating

4

Taking everything into account, MYPS scores 4 out of 10 in our fundamental rating. MYPS was compared to 80 industry peers in the Entertainment industry. No worries on liquidiy or solvency for MYPS as it has an excellent financial health rating, but there are worries on the profitability. MYPS is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year MYPS has reported negative net income.
In the past year MYPS had a positive cash flow from operations.
In multiple years MYPS reported negative net income over the last 5 years.
In the past 5 years MYPS always reported a positive cash flow from operatings.
MYPS Yearly Net Income VS EBIT VS OCF VS FCFMYPS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

1.2 Ratios

MYPS has a worse Return On Assets (-9.91%) than 68.75% of its industry peers.
Looking at the Return On Equity, with a value of -12.78%, MYPS is in line with its industry, outperforming 42.50% of the companies in the same industry.
Industry RankSector Rank
ROA -9.91%
ROE -12.78%
ROIC N/A
ROA(3y)-6.41%
ROA(5y)-1.3%
ROE(3y)-8.11%
ROE(5y)-1.5%
ROIC(3y)N/A
ROIC(5y)N/A
MYPS Yearly ROA, ROE, ROICMYPS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Gross Margin of MYPS (74.70%) is better than 86.25% of its industry peers.
MYPS's Gross Margin has improved in the last couple of years.
MYPS does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 74.7%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.2%
GM growth 5Y2.4%
MYPS Yearly Profit, Operating, Gross MarginsMYPS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

9

2. Health

2.1 Basic Checks

MYPS does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for MYPS has been reduced compared to 1 year ago.
The number of shares outstanding for MYPS has been reduced compared to 5 years ago.
MYPS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYPS Yearly Shares OutstandingMYPS Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
MYPS Yearly Total Debt VS Total AssetsMYPS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

MYPS has an Altman-Z score of 2.00. This is not the best score and indicates that MYPS is in the grey zone with still only limited risk for bankruptcy at the moment.
MYPS's Altman-Z score of 2.00 is fine compared to the rest of the industry. MYPS outperforms 62.50% of its industry peers.
There is no outstanding debt for MYPS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 2
ROIC/WACCN/A
WACC8.77%
MYPS Yearly LT Debt VS Equity VS FCFMYPS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

MYPS has a Current Ratio of 3.65. This indicates that MYPS is financially healthy and has no problem in meeting its short term obligations.
MYPS has a Current ratio of 3.65. This is amongst the best in the industry. MYPS outperforms 92.50% of its industry peers.
A Quick Ratio of 3.65 indicates that MYPS has no problem at all paying its short term obligations.
MYPS has a Quick ratio of 3.65. This is amongst the best in the industry. MYPS outperforms 92.50% of its industry peers.
Industry RankSector Rank
Current Ratio 3.65
Quick Ratio 3.65
MYPS Yearly Current Assets VS Current LiabilitesMYPS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

More info and screens

2

3. Growth

3.1 Past

The earnings per share for MYPS have decreased strongly by -71.43% in the last year.
MYPS shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -13.95%.
The Revenue has been growing slightly by 3.87% on average over the past years.
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-13.95%
Revenue growth 3Y0.23%
Revenue growth 5Y3.87%
Sales Q2Q%-18.26%

3.2 Future

Based on estimates for the next years, MYPS will show a very strong growth in Earnings Per Share. The EPS will grow by 28.52% on average per year.
MYPS is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -5.05% yearly.
EPS Next Y64.07%
EPS Next 2Y34.19%
EPS Next 3Y28.52%
EPS Next 5YN/A
Revenue Next Year-14.56%
Revenue Next 2Y-7.83%
Revenue Next 3Y-4.21%
Revenue Next 5Y-5.05%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MYPS Yearly Revenue VS EstimatesMYPS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M
MYPS Yearly EPS VS EstimatesMYPS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 -0.1 -0.2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for MYPS. In the last year negative earnings were reported.
Also next year MYPS is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYPS Price Earnings VS Forward Price EarningsMYPS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

MYPS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. MYPS is cheaper than 96.25% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, MYPS is valued cheaply inside the industry as 95.00% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 4.65
EV/EBITDA 0.19
MYPS Per share dataMYPS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2

4.3 Compensation for Growth

A more expensive valuation may be justified as MYPS's earnings are expected to grow with 28.52% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.19%
EPS Next 3Y28.52%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for MYPS!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

PLAYSTUDIOS INC

NASDAQ:MYPS (10/3/2025, 8:00:01 PM)

After market: 0.95 0 (0%)

0.95

+0.01 (+0.76%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)08-04 2025-08-04/amc
Earnings (Next)11-03 2025-11-03/amc
Inst Owners36.87%
Inst Owner Change-3.47%
Ins Owners3.06%
Ins Owner Change-0.24%
Market Cap119.08M
Analysts78.18
Price Target2.93 (208.42%)
Short Float %0.57%
Short Ratio1.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-33.08%
Min EPS beat(2)-50.83%
Max EPS beat(2)-15.34%
EPS beat(4)1
Avg EPS beat(4)-39.63%
Min EPS beat(4)-110.08%
Max EPS beat(4)17.72%
EPS beat(8)3
Avg EPS beat(8)-72.79%
EPS beat(12)7
Avg EPS beat(12)-20.41%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-4.97%
Min Revenue beat(2)-5.61%
Max Revenue beat(2)-4.32%
Revenue beat(4)1
Avg Revenue beat(4)-2.39%
Min Revenue beat(4)-5.61%
Max Revenue beat(4)1.83%
Revenue beat(8)3
Avg Revenue beat(8)-2.21%
Revenue beat(12)6
Avg Revenue beat(12)0.27%
Revenue beat(16)7
Avg Revenue beat(16)-0.41%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-124.24%
EPS NY rev (1m)0%
EPS NY rev (3m)-63.16%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-6.19%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.92%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.46
P/FCF 4.65
P/OCF 2.76
P/B 0.49
P/tB 1.09
EV/EBITDA 0.19
EPS(TTM)-0.24
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)0.2
FCFY21.51%
OCF(TTM)0.34
OCFY36.24%
SpS2.08
BVpS1.96
TBVpS0.88
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -9.91%
ROE -12.78%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 74.7%
FCFM 9.81%
ROA(3y)-6.41%
ROA(5y)-1.3%
ROE(3y)-8.11%
ROE(5y)-1.5%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.2%
GM growth 5Y2.4%
F-Score4
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 42.37%
Cap/Sales 6.72%
Interest Coverage N/A
Cash Conversion 130.57%
Profit Quality N/A
Current Ratio 3.65
Quick Ratio 3.65
Altman-Z 2
F-Score4
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)71.79%
Cap/Depr(5y)97.26%
Cap/Sales(3y)9.92%
Cap/Sales(5y)10.8%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y64.07%
EPS Next 2Y34.19%
EPS Next 3Y28.52%
EPS Next 5YN/A
Revenue 1Y (TTM)-13.95%
Revenue growth 3Y0.23%
Revenue growth 5Y3.87%
Sales Q2Q%-18.26%
Revenue Next Year-14.56%
Revenue Next 2Y-7.83%
Revenue Next 3Y-4.21%
Revenue Next 5Y-5.05%
EBIT growth 1Y-13.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year305.55%
EBIT Next 3Y62.91%
EBIT Next 5Y49.12%
FCF growth 1Y720.96%
FCF growth 3YN/A
FCF growth 5Y16.46%
OCF growth 1Y18.81%
OCF growth 3Y10.52%
OCF growth 5Y4.85%